| 依达拉奉联合低分子肝素治疗进展性卒中的疗效观察 |
| |
| 引用本文： | 段红利,刘骅.依达拉奉联合低分子肝素治疗进展性卒中的疗效观察[J].西部医学,2011,23(1):86-87,90. |
| |
| 作者姓名： | 段红利 刘骅 |
| |
| 作者单位： | 宜宾市第二人民医院神经内科,四川,宜宾,644000 |
| |
| 摘 要： | 目的观察依达拉奉联合低分子肝素治疗进展性卒中的疗效。方法对140例急性进展性卒中的患者随机分为依达拉奉联合低分子肝素治疗组（n=70）和低分子肝素对照纽（n=70）。治疗组在常规治疗的基础上加用依达拉奉30mg加入生理盐水100ml中静滴，2次／d，连用14d，同时给予低分子肝素5000U腹部皮下注射2次／d，连用7d。对照组在常规治疗的基础上只加用低分子肝素。于治疗前及治疗第14d分别进行临床疗效及神经功能缺损评分。结果两组于治疗前后神经功能缺损评分、临床疗效均有改善，治疗组总有效率90．00％，对照组总有效率75．71％，治疗组改善更明显，与对照组相比有显著性差异（P〈0．01）。结论依这拉奉联合低分子肝素治疗进展性卒中疗效确切，不良反应少，值得推广。
|
| 关 键 词： | 依达拉奉 低分子肝素 进展性卒中 疗效 |
Clinical observation of treatment of progressive stroke with edaravone and low molecular weight heparin |
| |
| DUAN Hong-li,LIU hua.Clinical observation of treatment of progressive stroke with edaravone and low molecular weight heparin[J].Medical Journal of West China,2011,23(1):86-87,90. |
| |
| Authors: | DUAN Hong-li LIU hua |
| |
| Institution: | DUAN Hong-li,LIU Hua(Department of Neurology,The Second People Hospital of Yibin,Yibin 644000,Sichuan,China) |
| |
| Abstract: | Objective To observe the clinical effect of treatment of progressive stroke with edaravone and low molecular weight heparin.Methods 140 patients with progressive stroke were randomly divided into two groups,treatment group(70 cases) treated with edaravone and low molecular weight heparin and control group(70 cases) treated with low molecular weight heparin only.With same normal basic treatments on the 2 groups,the treatment group was intravenous drop-injected with 30mg edaravone twice a day for 14 days.Mean... |
| |
| Keywords: | Edaravone Low molecular weight heparin Progresive stroke Therapeutic effect |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
